位置:首页 > 蛋白库 > MAP1B_PLAF7
MAP1B_PLAF7
ID   MAP1B_PLAF7             Reviewed;         517 AA.
AC   Q8IJP2;
DT   07-OCT-2020, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2003, sequence version 1.
DT   03-AUG-2022, entry version 141.
DE   RecName: Full=Methionine aminopeptidase 1b {ECO:0000303|PubMed:16983082};
DE            EC=3.4.11.18 {ECO:0000255|RuleBase:RU003653, ECO:0000269|PubMed:16983082, ECO:0000269|PubMed:27023914};
DE   AltName: Full=PfMetAP1b {ECO:0000303|PubMed:16983082};
GN   Name=METAP1b {ECO:0000303|PubMed:16983082};
GN   ORFNames=PF3D7_1015300 {ECO:0000312|EMBL:CZT98405.1};
OS   Plasmodium falciparum (isolate 3D7).
OC   Eukaryota; Sar; Alveolata; Apicomplexa; Aconoidasida; Haemosporida;
OC   Plasmodiidae; Plasmodium; Plasmodium (Laverania).
OX   NCBI_TaxID=36329 {ECO:0000312|Proteomes:UP000001450};
RN   [1] {ECO:0000312|Proteomes:UP000001450}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=3D7 {ECO:0000312|Proteomes:UP000001450};
RX   PubMed=12368864; DOI=10.1038/nature01097;
RA   Gardner M.J., Hall N., Fung E., White O., Berriman M., Hyman R.W.,
RA   Carlton J.M., Pain A., Nelson K.E., Bowman S., Paulsen I.T., James K.D.,
RA   Eisen J.A., Rutherford K.M., Salzberg S.L., Craig A., Kyes S., Chan M.-S.,
RA   Nene V., Shallom S.J., Suh B., Peterson J., Angiuoli S., Pertea M.,
RA   Allen J., Selengut J., Haft D., Mather M.W., Vaidya A.B., Martin D.M.A.,
RA   Fairlamb A.H., Fraunholz M.J., Roos D.S., Ralph S.A., McFadden G.I.,
RA   Cummings L.M., Subramanian G.M., Mungall C., Venter J.C., Carucci D.J.,
RA   Hoffman S.L., Newbold C., Davis R.W., Fraser C.M., Barrell B.G.;
RT   "Genome sequence of the human malaria parasite Plasmodium falciparum.";
RL   Nature 419:498-511(2002).
RN   [2] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RX   PubMed=16983082; DOI=10.1073/pnas.0604101103;
RA   Chen X., Chong C.R., Shi L., Yoshimoto T., Sullivan D.J. Jr., Liu J.O.;
RT   "Inhibitors of Plasmodium falciparum methionine aminopeptidase 1b possess
RT   antimalarial activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:14548-14553(2006).
RN   [3] {ECO:0000305}
RP   FUNCTION, CATALYTIC ACTIVITY, COFACTOR, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   MUTAGENESIS OF CYS-316.
RX   PubMed=27023914; DOI=10.1007/s00253-016-7470-3;
RA   Calcagno S., Klein C.D.;
RT   "N-Terminal methionine processing by the zinc-activated Plasmodium
RT   falciparum methionine aminopeptidase 1b.";
RL   Appl. Microbiol. Biotechnol. 100:7091-7102(2016).
RN   [4] {ECO:0007744|PDB:3S6B}
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 168-517 IN COMPLEX WITH IRON.
RA   Wernimont A.K., Artz J.D., Crombet L., Lew J., Weadge J., Arrowsmith C.H.,
RA   Edwards A.M., Weigelt J., Bountra C., Hui R., Hills T.;
RT   "Crystal structure of methionine aminopeptidase 1b from Plasmodium
RT   Falciparum, PF10_0150.";
RL   Submitted (MAY-2011) to the PDB data bank.
CC   -!- FUNCTION: Cotranslationally removes the N-terminal methionine from
CC       nascent proteins (PubMed:16983082, PubMed:27023914). The N-terminal
CC       methionine is often cleaved when the second residue in the primary
CC       sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or
CC       Val) (By similarity). May play an important role in parasite growth
CC       during the blood asexual stage (PubMed:16983082).
CC       {ECO:0000255|RuleBase:RU003653, ECO:0000269|PubMed:16983082,
CC       ECO:0000269|PubMed:27023914}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=Release of N-terminal amino acids, preferentially methionine,
CC         from peptides and arylamides.; EC=3.4.11.18;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:16983082, ECO:0000269|PubMed:27023914};
CC   -!- COFACTOR:
CC       Name=Co(2+); Xref=ChEBI:CHEBI:48828;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:27023914};
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:27023914};
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:27023914};
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_03174,
CC         ECO:0000269|PubMed:27023914};
CC       Note=Highest activity with zinc and cobalt ions, and low activity with
CC       manganese or divalent iron ions (PubMed:27023914). Binds 2 divalent
CC       metal cations per subunit. Has a high-affinity and a low affinity
CC       metal-binding site. The true nature of the physiological cofactor is
CC       under debate. The enzyme is active with cobalt, zinc, manganese or
CC       divalent iron ions. Most likely, methionine aminopeptidases function as
CC       mononuclear Fe(2+)-metalloproteases under physiological conditions, and
CC       the catalytically relevant metal-binding site has been assigned to the
CC       histidine-containing high-affinity site (By similarity).
CC       {ECO:0000255|HAMAP-Rule:MF_03174, ECO:0000269|PubMed:27023914};
CC   -!- ACTIVITY REGULATION: Inhibited by pyrimidine derivative XC11.
CC       {ECO:0000269|PubMed:16983082}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=327.3 uM for methionine containing-oligopeptide
CC         {ECO:0000269|PubMed:16983082};
CC         KM=845.08 uM for Met-Gly-Met-Met peptide (in presence of 1 uM Zn(2+),
CC         at 37 degrees Celsius, pH 7.5) {ECO:0000269|PubMed:27023914};
CC         KM=1117.7 uM for Met-Gly-Met-Met peptide (in presence of 10 uM
CC         Zn(2+), at 37 degrees Celsius, pH 7.5) {ECO:0000269|PubMed:27023914};
CC         KM=1662.4 uM for Met-Gly-Met-Met peptide (in presence of 100 uM
CC         Zn(2+), at 37 degrees Celsius, pH 7.5) {ECO:0000269|PubMed:27023914};
CC         KM=1759 uM for Met-Gly-Met-Met peptide (in presence of 1 uM Co(2+),
CC         at 37 degrees Celsius, pH 7.5) {ECO:0000269|PubMed:27023914};
CC         KM=1142.4 uM for Met-Gly-Met-Met peptide (in presence of 10 uM
CC         Co(2+), at 37 degrees Celsius, pH 7.5) {ECO:0000269|PubMed:27023914};
CC         KM=1061.5 uM for Met-Gly-Met-Met peptide (in presence of 100 uM
CC         Co(2+), at 37 degrees Celsius, pH 7.5) {ECO:0000269|PubMed:27023914};
CC         Note=kcat is 13.9 min(-1) with methionine containing-oligopeptide as
CC         substrate (PubMed:16983082). kcat is 552.49 min(-1) in presence of 1
CC         uM Zn(2+), 442.48 min(-1) in presence of 10 uM Zn(2+) and 364.30
CC         min(-1) in presence of 100 uM Zn(2+), with Met-Gly-Met-Met peptide as
CC         substrate (PubMed:27023914). kcat is 1005 min(-1) in presence of 1 uM
CC         Co(2+), 583.09 min(-1) in presence of 10 uM Co(2+) and 547.95 min(-1)
CC         in presence of 100 uM Co(2+), with Met-Gly-Met-Met peptide as
CC         substrate (PubMed:27023914). {ECO:0000269|PubMed:16983082,
CC         ECO:0000269|PubMed:27023914};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:27023914};
CC       Temperature dependence:
CC         Optimum temperature is 37 degrees Celsius (PubMed:27023914). However,
CC         has substantial activity at 25 degrees Celsius (PubMed:27023914).
CC         {ECO:0000269|PubMed:27023914};
CC   -!- SIMILARITY: Belongs to the peptidase M24A family. Methionine
CC       aminopeptidase type 1 subfamily. {ECO:0000255|HAMAP-Rule:MF_03174}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; LN999944; CZT98405.1; -; Genomic_DNA.
DR   RefSeq; XP_001347435.1; XM_001347399.1.
DR   PDB; 3S6B; X-ray; 1.95 A; A=168-517.
DR   PDBsum; 3S6B; -.
DR   AlphaFoldDB; Q8IJP2; -.
DR   SMR; Q8IJP2; -.
DR   IntAct; Q8IJP2; 2.
DR   STRING; 5833.PF10_0150; -.
DR   MEROPS; M24.017; -.
DR   PRIDE; Q8IJP2; -.
DR   EnsemblProtists; CZT98405; CZT98405; PF3D7_1015300.
DR   GeneID; 810308; -.
DR   KEGG; pfa:PF3D7_1015300; -.
DR   VEuPathDB; PlasmoDB:PF3D7_1015300; -.
DR   HOGENOM; CLU_015857_2_0_1; -.
DR   InParanoid; Q8IJP2; -.
DR   OMA; SKMYVMP; -.
DR   PhylomeDB; Q8IJP2; -.
DR   Proteomes; UP000001450; Chromosome 10.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0070006; F:metalloaminopeptidase activity; IBA:GO_Central.
DR   GO; GO:0008235; F:metalloexopeptidase activity; ISS:GeneDB.
DR   GO; GO:0035551; P:protein initiator methionine removal involved in protein maturation; IBA:GO_Central.
DR   GO; GO:0006508; P:proteolysis; ISS:GeneDB.
DR   CDD; cd01086; MetAP1; 1.
DR   Gene3D; 3.90.230.10; -; 1.
DR   HAMAP; MF_01974; MetAP_1; 1.
DR   InterPro; IPR036005; Creatinase/aminopeptidase-like.
DR   InterPro; IPR000994; Pept_M24.
DR   InterPro; IPR001714; Pept_M24_MAP.
DR   InterPro; IPR002467; Pept_M24A_MAP1.
DR   InterPro; IPR031615; Zfn-C6H2.
DR   Pfam; PF00557; Peptidase_M24; 1.
DR   Pfam; PF15801; zf-C6H2; 1.
DR   PRINTS; PR00599; MAPEPTIDASE.
DR   SUPFAM; SSF55920; SSF55920; 1.
DR   TIGRFAMs; TIGR00500; met_pdase_I; 1.
DR   PROSITE; PS00680; MAP_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Aminopeptidase; Hydrolase; Metal-binding; Protease;
KW   Reference proteome.
FT   CHAIN           1..517
FT                   /note="Methionine aminopeptidase 1b"
FT                   /id="PRO_0000451190"
FT   REGION          74..94
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        76..94
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         325
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174"
FT   BINDING         342
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174"
FT   BINDING         353
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174"
FT   BINDING         353
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0007744|PDB:3S6B"
FT   BINDING         419
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0007744|PDB:3S6B"
FT   BINDING         426
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174"
FT   BINDING         452
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0007744|PDB:3S6B"
FT   BINDING         483
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174"
FT   BINDING         483
FT                   /ligand="a divalent metal cation"
FT                   /ligand_id="ChEBI:CHEBI:60240"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_03174,
FT                   ECO:0007744|PDB:3S6B"
FT   SITE            316
FT                   /note="Important for substrate specificity to methionine"
FT                   /evidence="ECO:0000269|PubMed:27023914"
FT   MUTAGEN         316
FT                   /note="C->S: 50% reduction in activity with Zn(2+) as
FT                   cofactor. Increases activity with Co(2+) as cofactor and
FT                   acquires new substrate specificity to leucine, tryptophan
FT                   and phenylalanine."
FT                   /evidence="ECO:0000269|PubMed:27023914"
FT   HELIX           173..180
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   TURN            183..185
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           192..196
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           200..203
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          209..211
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   TURN            231..235
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           239..242
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           255..277
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           285..298
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   TURN            304..307
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           308..310
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          313..319
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          322..324
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          338..347
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          350..359
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           363..365
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           368..387
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           396..406
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   TURN            407..409
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          418..420
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          422..431
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          433..436
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          448..451
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          454..458
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          462..464
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          471..473
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          479..481
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          483..489
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   STRAND          492..495
FT                   /evidence="ECO:0007829|PDB:3S6B"
FT   HELIX           512..514
FT                   /evidence="ECO:0007829|PDB:3S6B"
SQ   SEQUENCE   517 AA;  59724 MW;  BD216A8F8D25E7AF CRC64;
     MANIDDIEKQ IENIKINSDD NKNNVSKNKN ILLNGVNLKD HEIKDNVKSV DYNNNNNEND
     TMNEINKHVK NDEYCNKENS NNNNNNNNNN NNNLDTQINE TLNLNEKFEK KNEENLCSGC
     KKVLIKKLSC PICLKNKIFS YFCNQECFKG SWKEHQKIHE NMNKENNEKE DHLKTIVKKH
     LSPENFDPTN RKYWVYDDHL KNFVNFKFTG DVRPWPLSKI NHVPSHIERP DYAISSIPES
     ELIYKRKSDI YVNNEEEIQR IREACILGRK TLDYAHTLVS PGVTTDEIDR KVHEFIIKNN
     AYPSTLNYYK FPKSCCTSVN EIVCHGIPDY RPLKSGDIIN IDISVFYKGV HSDLNETYFV
     GDINDVPKEG KELVETCYFS LMEAIKKCKP GMFYKNIGTL IDAYVSKKNF SVVRSYSGHG
     VGKLFHSNPT VPHFKKNKAV GIMKPGHVFT IEPMINQGHY SDVLWPDQWT SATSDGKLSA
     QFEHTLLITN NGVEILTKRT QDSPPLGFDT KDELYYN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025